Search

everythinglearnresearchcommunity

for

Search:↓

1% topical minoxidil solution significantly improved hair growth in Japanese women with androgenetic alopecia, with no major side effects.

Long-term hair dye use may increase testosterone levels in women.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Oral iron therapy may help reduce hair loss in iron-deficient women.

Omega-3 fatty acids may help manage hair loss in middle-aged women.

Tailored supplementation of calcium, magnesium, and vitamin D based on hair analysis may improve bone health.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Iron intake has not been proven to maintain normal hair growth.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

NAFLD is common in women with PCOS and may signal metabolic syndrome.

The treatment improved hair growth and quality in women with hair loss.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Vitamin D may help with certain types of hair loss in women.

Nursing women in the West Bank with higher income and non-smoking habits have higher blood zinc levels.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Low iron levels can cause hair loss and restless legs in non-anemic women.

Women with PCOS have different hormone levels compared to those without PCOS.

Reticulocyte hemoglobin content is the best indicator of iron deficiency in women with diffuse non-scarring hair loss.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.